(Q35053441)

6 August 2017

1 reference

title

Drug-eluting stents in vascular intervention (English)

1 reference

6 August 2017

Rossella Fattori

1

1 reference

PubMed ID

12547552

6 August 2017

Tommaso Piva

series ordinal

2

1 reference

PubMed ID

12547552

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

361

1 reference

6 August 2017

247-249

1 reference

6 August 2017

9353

1 reference

Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Overcoming restenosis with sirolimus: from alphabet soup to clinical reality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Stenting in small coronary arteries (SISCA) trial. A randomized comparison between balloon angioplasty and the heparin-coated beStent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Morphological predictors of restenosis after coronary stenting in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

Transluminal dilatation of coronary-artery stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912275-1

7 January 2021

10.1016/S0140-6736(03)12275-1

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12547552